These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31025490)

  • 41. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.
    Scarpa A; Ralli M; Cassandro C; Gioacchini FM; Alicandri-Ciufelli M; Viola P; Chiarella G; de Vincentiis M; Cassandro E
    Am J Otolaryngol; 2019; 40(6):102289. PubMed ID: 31537428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH; Gamst AC; Anderson JP; Harris JP
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratympanic gentamicin compared with placebo for Ménière's disease.
    de Amesti F; Santander MJ; Winter M
    Medwave; 2022 Mar; 22(2):e8696. PubMed ID: 35323825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS; Johnson IJ
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF; Renk E; Rauch SD; Xu HX
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low Dose Intratympanic Gentamicin in Ménière's Disease.
    Faizal B; Rajan A
    Indian J Otolaryngol Head Neck Surg; 2022 Aug; 74(Suppl 1):320-325. PubMed ID: 36032834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.
    Boleas-Aguirre MS; Lin FR; Della Santina CC; Minor LB; Carey JP
    Otol Neurotol; 2008 Jan; 29(1):33-8. PubMed ID: 18199956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Ménière's disease: A systematic review and meta-analysis.
    Marques PS; Dias CC; Perez-Fernandez N; Spratley J
    Auris Nasus Larynx; 2018 Oct; 45(5):943-951. PubMed ID: 29402608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease.
    Ardıç FN; Tümkaya F; Aykal K; Çabuk B
    J Int Adv Otol; 2017 Aug; 13(2):243-246. PubMed ID: 28716762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
    Yazdani N; Nejadian F; Rezazadeh N; Hoseinabadi R; Karimi E; Gharibi R; Dabiri S
    Acta Med Iran; 2018 Jan; 56(1):43-48. PubMed ID: 29436794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
    Lambert PR; Carey J; Mikulec AA; LeBel C;
    Otol Neurotol; 2016 Dec; 37(10):1669-1676. PubMed ID: 27749754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intratympanic corticosteroids injections: a systematic review of literature.
    Lavigne P; Lavigne F; Saliba I
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2271-8. PubMed ID: 26100030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.